5500/20 vs. SABR or Brachytherapy for PRimary OligoMetastatic Prostate Cancer Treatment (PROMPT)

Clinical trial NCT04610372 · RECRUITING

Trial details

NCT number: NCT04610372
Sponsor: British Columbia Cancer Agency
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Oligometastatic Prostate Cancer

Start date: 2021-07-12
Primary completion: 2030-06-30
Enrollment: 168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.